69OA small molecule human PD-1/PD-L1 inhibitor promotes T cell immune activation and reduces tumor growth in a preclinical model. (17th December 2018) - Vilalta Colomer, M; Punna, S; Li, S; Malathong, V; Lange, C; McMurtrie, D; Yang, J; Roth, H; McMahon, J; Campbell, J J; Ertl, L S; Ong, R; et al.